For research use only. Not for therapeutic Use.
Ceftobiprole medocaril sodium（Cat No.:I024349）is a broad-spectrum cephalosporin antibiotic used to treat bacterial infections, including complicated skin and soft tissue infections (cSSTIs) and pneumonia. It works by inhibiting bacterial cell wall synthesis, leading to the death of susceptible bacteria. Ceftobiprole targets a range of Gram-positive and Gram-negative organisms, including methicillin-resistant Staphylococcus aureus (MRSA), making it particularly valuable in treating multidrug-resistant infections. As a prodrug, ceftobiprole medocaril sodium is metabolized in the body to its active form, ceftobiprole, which exerts the antibiotic effect. It is used in both hospital and outpatient settings.
| CAS Number | 252188-71-9 |
| Synonyms | sodium;(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-hydroxyiminoacetyl]amino]-3-[(E)-[1-[(3R)-1-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxycarbonyl]pyrrolidin-3-yl]-2-oxopyrrolidin-3-ylidene]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
| Molecular Formula | C26H25N8NaO11S2 |
| Purity | ≥95% |
| IUPAC Name | sodium;(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-hydroxyiminoacetyl]amino]-3-[(E)-[1-[(3R)-1-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxycarbonyl]pyrrolidin-3-yl]-2-oxopyrrolidin-3-ylidene]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
| InChI | InChI=1S/C26H26N8O11S2.Na/c1-10-14(45-26(41)44-10)8-43-25(40)32-4-3-13(7-32)33-5-2-11(20(33)36)6-12-9-46-22-16(21(37)34(22)17(12)23(38)39)28-19(35)15(30-42)18-29-24(27)47-31-18;/h6,13,16,22,42H,2-5,7-9H2,1H3,(H,28,35)(H,38,39)(H2,27,29,31);/q;+1/p-1/b11-6+,30-15-;/t13-,16-,22-;/m1./s1 |
| InChIKey | MFAWUGGPPMTWPU-LCJFHXTKSA-M |
| SMILES | CC1=C(OC(=O)O1)COC(=O)N2CC[C@H](C2)N3CC/C(=C\C4=C(N5[C@@H]([C@@H](C5=O)NC(=O)/C(=N\O)/C6=NSC(=N6)N)SC4)C(=O)[O-])/C3=O.[Na+] |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
